GID SVF-2

DEVICE3 trials

Sponsors

GID BIO, Inc.

Conditions

Androgenetic AlopeciaErectile DysfunctionOsteoarthritis (OA)

Unknown Phase

Adipose-derived SVF for Treatment of Alopecia

CompletedNCT02626780

GID BIO, Inc.Androgenetic Alopecia

Start: 2016-07-20End: 2017-01-22Updated: 2019-03-21

Adipose-derived SVF for the Treatment of Knee OA

CompletedNCT02726945

GID BIO, Inc.Osteoarthritis (OA)

Start: 2016-04-30End: 2019-10-01Updated: 2025-04-25

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)

WithdrawnNCT03886402

GID BIO, Inc.Erectile Dysfunction

Start: 2021-10-31End: 2022-10-31Updated: 2025-04-24

Related Papers

Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial

The American Journal of Sports Medicine2020-02-28179 citations